Stoke Therapeutics Inc Headquarters
Looking for information about Stoke Therapeutics Inc Headquarters? The links below have collected all the necessary data.
Contact Us – Stoke Therapeutics
- https://www.stoketherapeutics.com/contact-us/
- Headquarters. 45 Wiggins Ave Bedford, MA 01730 781-430-8200. Office. 139 Main Street, 4th Floor Cambridge, MA 02142. © 2021 Stoke Therapeutics, all rights reserved.
Stoke Therapeutics – Restoring Missing Proteins ...
- https://www.stoketherapeutics.com/
- Stoke Therapeutics – Restoring Missing Proteins – Restoring the Future. Read our statement on COVID-19. Restoring. missing. proteins. Restoring. the. future. Stoke is pioneering a new way to treat the underlying causes of severe genetic diseases by precisely upregulating protein expression.
About Us – Stoke Therapeutics
- https://www.stoketherapeutics.com/about-us/
- Stoke is pioneering a new way to treat the underlying cause of severe genetic diseases by precisely upregulating protein expression. We develop antisense oligonucleotide medicines that increase gene expression to treat genetic epilepsies and other severe monogenic diseases, including genetic conditions affecting the central nervous system, eye, liver and kidney.
Stoke Therapeutics Company Profile - Office Locations ...
- https://craft.co/stoke-therapeutics
- Jun 19, 2019 · Stoke Therapeutics Inc. shares rocketed 46% in their trading debut Wednesday, after the company's initial public offering priced above its $14 to $16 price range. The company sold 7.9 million shares priced at $18 each to raise $142 million.Employees: 44
Stoke Therapeutics - Crunchbase Company Profile & Funding
- https://www.crunchbase.com/organization/stoke-therapeutics
- Headquarters Regions Greater Boston Area, East Coast, New England. Founded Date Jan 1, 2014. Founders Edward Kaye, Huw Nash, Isabel Aznarez. Operating Status Active. Last Funding Type Post-IPO Equity. Stock Symbol NASDAQ:STOK. Company Type For Profit. Contact Email [email protected]. Phone Number 781-430-8200.Founder: Edward Kaye, Huw Nash, Isabel Aznarez
Stoke Therapeutics Inc - Company Profile and News ...
- https://www.bloomberg.com/profile/company/STOK:US
- Stoke Therapeutics, Inc. operates as a biotechnology company. The Company develops antisense oligonucleotide medicines and therapies that increase target gene expression to treat diseases caused ...Employees: 79
Stoke Therapeutics - Overview, News & Competitors ...
- https://www.zoominfo.com/c/stoke-therapeutics-inc/398830664
- Stoke Therapeutics to Present at Upcoming Investor Conferences in August BEDFORD, Mass.--(BUSINESS WIRE)--Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated to addressing the underlying cause of severe diseases by up-regulating protein expression with RNA-based medicines, today announced that Chief Executive Officer Edward M. Kaye, M.D., will present at two …Employees: 29
Our Story – Stoke Therapeutics
- https://www.stoketherapeutics.com/our-story/
- Teaming up with Dr. Nash, the three founded Stoke Therapeutics. Backed by a veteran leadership team and $40 million from Apple Tree Partners, Stoke emerged from stealth mode in January 2018. Stoke subsequently added $90 million in Series B financing from a syndicate of investors in October 2018. Rapid progress toward the clinic.
Stoke Therapeutics LinkedIn
- https://www.linkedin.com/company/stoke-therapeutics
- Stoke Therapeutics 4,717 followers on LinkedIn. Stoke Therapeutics is pioneering a new way to treat the underlying causes of severe #geneticdiseases by precisely upregulating protein expression.
Have you found Stoke Therapeutics Inc Headquarters information?
On our site you can find many other information about headquarters of any company. Research information about other companies.